|
Longfin Corp.
April 3, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Longfin Corp. (“Longfin” or the “Company”) (NASDAQ: LFIN) concerning potential securities law violations. Investors who purchased Longfin securities in the Company’s December 2017 initial public offering (the “IPO”) or since the IPO may be affected.
|
|
L'Oreal
March 29, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of consumers of L’Oréal and Maybelline Cosmetic products.
|
|
Micro Focus International plc
March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Micro focus International plc (“Micro Focus” or the “Company”) (NYSE: MFGP), including purchasers of Micro Focus American Depositary Receipts (“ADRs”).
|
|
BRF S.A.
March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of BRF S.A. (“BRF” or the “Company”) (NYSE: BRFS).
|
|
VelocityShares Daily Inverse VIX Short Term ETNs
March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Credit Suisse VelocityShares Daily Inverse VIX Short Term ETNs (NASDAQ: XIV).
|
|
Acadia Healthcare Company, Inc.
March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. (“Acadia Healthcare” or the “Company”) (NASDAQ: ACHC).
|
|
Foot Locker, Inc.
March 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Foot Locker, Inc. (“Foot Locker” or the “Company”) (NYSE: FL).
|
|
Facebook, Inc.
March 19, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Facebook Inc. (“Facebook” or the “Company”) (NASDAQ: FB) concerning potential securities law violations. Investors who purchased Facebook securities may be affected.
|
|
TrueCar, Inc.
March 16, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigating of potential claims on behalf of investors of TrueCar, Inc. (“TrueCar” or the “Company”) (NASDAQ: TRUE) for violations of the federal securities laws. Investors who purchased TrueCar common stock may be affected.
|
|
AutoWeb, Inc.
March 12, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of AutoWeb, Inc. (“AutoWeb or the “Company”) (NASDAQ: AUTO), formerly Autobytel, Inc. Investors who purchased AutoWeb common stock may be affected.
|
|
WageWorks, Inc.
March 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating San Mateo, California-based WageWorks, Inc. (“WageWorks” or the “Company”) (NYSE: WAGE) concerning potential violations of the federal securities laws.
|
|
Akorn, Inc.
February 27, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Akorn, Inc. (“Akorn” or the “Company”) (NASDAQ: AKRX), a specialty generic pharmaceutical company, concerning potential securities law violations. Investors who purchased Akorn securities may be affected.
|
|
Aflac Incorporated
February 26, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Aflac Incorporated (“Aflac” or the “Company”) (NYSE: AFL). Investors who purchased Aflac common stock between February 27, 2013 and January 11, 2018, inclusive (the “Class Period”), may be affected.
|
|
Synergy Pharmaceuticals Inc.
February 23, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Synergy Pharmaceuticals Inc. (“Synergy” or the “Company”) (NASDAQ: SGYP). Investors who purchased Synergy securities between September 5, 2017 and November 14, 2017, inclusive (the “Class Period”), may be affected.
|
|
Super Micro Computer, Inc.
February 23, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI). Investors who purchased Super Micro securities between August 5, 2016 and January 30, 2018, inclusive (the “Class Period”), may be affected.
|
|
MiMedx Group, Inc.
February 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG), a developer and marketer of regenerative and therapeutic biologics, concerning potential securities law violations. Investors who purchased MiMedx shares may be affected.
|
|
Ubiquiti Networks, Inc.
February 20, 2018 – Kaplan Fox Announces Investigation of Ubiquiti Networks, Inc.
|
|
Quantum Corporation
February 12, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Quantum Corporation (“Quantum” or the “Company”) (NYSE: QTM). Investors who purchased shares of Quantum common stock may be affected.
|
|
TrueCar, Inc.
February 7, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of TrueCar, Inc. (“TrueCar” or the “Company”) (NASDAQ: TRUE). Investors who purchased TrueCar common stock may be affected.
|
|
MetLife, Inc.
January 31, 2018 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating MetLife, Inc. (“MetLife” or the “Company”) (NYSE: MET) on behalf of investors who purchased MetLife securities.
|
|
Obalon Therapeutics, Inc.
January 24, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN). Investors who purchased Obalon common stock may be affected.
|
|
Aerohive Networks, Inc.
January 24, 2018 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Aerohive Networks, Inc. (“Aerohive” or the “Company”) (Nasdaq: HIVE) on behalf of investors who purchased Aerohive securities.
|
|
GoPro, Inc.
January 17, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GoPro, Inc. (“GoPro” or the “Company”) (NASDAQ: GPRO). Investors who purchased GoPro securities between August 4, 2017 and January 5, 2018, inclusive (the “Class Period”) may be affected.
|
|
AZZ, Inc.
January 10, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of AZZ Inc. (“AZZ” or the “Company”) (NYSE: AZZ). Investors who purchased shares of AZZ securities may be affected.
|
|
Capitala Finance Corp.
January 9, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Capitala Finance Corp. (“Capitala ” or the “Company”) (NASDAQ: CPTA). Investors who purchased Capitala shares may be affected.
|
|
The Crypto Company
January 9, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Crypto Company (“Crypto” or the “Company”) (OTC: CRCW). Crypto is a technology company that operates in the digital currencies and blockchain sector. The Company offers a portfolio of digital assets, technologies, and consulting services to the blockchain and cryptocurrency markets. Investors who purchased Crypto common shares may be affected.
|
|
Liberty Tax, Inc.
December 12, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Liberty Tax, Inc. (“Liberty Tax” or the “Company”) (NASDAQ: TAX). Investors who purchased shares of Liberty Tax securities may be affected.
|
|
Omega Healthcare Investors, Inc.
November 29, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Omega Healthcare Investors, Inc. (“Omega Healthcare” or the “Company”) (NYSE: OHI), a real estate investment trust (REIT) that invests in income producing healthcare facilities. Investors who purchased Omega Healthcare common stock may be affected.
|
|
Triangle Capital Corporation
November 16, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Triangle Capital Corporation ("Triangle Capital" or the "Company") (NYSE: TCAP). Investors who purchased Triangle Capital common stock may be affected.
|
|
Acorda Therapeutics, Inc.
November 15, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision Healthcare” or the “Company”) (NYSE: EVHC).
|
